The use of sulfonamides in urinary tract infection.
D000743:Anemia, Hemolytic / Q000139:chemically induced; D003875:Drug Eruptions; D006417:Hematuria / Q000139:chemically induced; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy; D009401:Nephrosis / Q000139:chemically induced; D013290:Streptococcal Infections / Q000517:prevention & control; D013411:Sulfadiazine / Q000009:adverse effects; D013416:Sulfamerazine / Q000008:administration & dosage / Q000009:adverse effects; D013418:Sulfamethazine / Q000008:administration & dosage / Q000009:adverse effects; D013419:Sulfamethizole / Q000008:administration & dosage; D013420:Sulfamethoxazole / Q000009:adverse effects; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D013449:Sulfonamides; D013411:Sulfadiazine; D013419:Sulfamethizole; D013418:Sulfamethazine; D013420:Sulfamethoxazole; D013416:Sulfamerazine